Skip to Content

7113 (Docusate 250 mg)

Pill imprint 7113 has been identified as Docusate sodium 250 mg.

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Docusate sodium 250 mg 7113
Discount Card Promo
Docusate sodium
Imprint:
7113
Strength:
250 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Laxatives
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00536-3757
Inactive Ingredients:
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
glycerin
polyethylene glycol
propylene glycol
water
sorbitol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide